SCHEMBL6763170

SCHEMBL6763170

CCCS(=O)(=O)NCC(C)c1ccc2cc(OCCNC(=O)N(C)c3ccccc3)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 1/20 0.41
CA4 P22748 7/20 0.40
CA12 O43570 4/20 0.40
CA9 Q16790 4/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
ACACB O00763 1/20 0.39
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
PPARG P37231 2/20 0.37
PPARD Q03181 2/20 0.37
PPARA Q07869 2/20 0.37
HRAS P01112 1/20 0.37
KRAS P01116 1/20 0.37
MAPK1 P28482 1/20 0.36
NTSR1 P30989 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6763167 0.88 GRIA4 (0.44) GRIA4CA4CA12CA9CA1
SCHEMBL6762172 0.85 RAB9A (0.47) GRIA4CA4CA12CA9CA1
SCHEMBL6763719 0.84 ACACB (0.47) GRIA4CA4CA12CA9CA1
SCHEMBL6759350 0.83 GRIA4 (0.47) GRIA4CA4CA12CA9CA1
SCHEMBL6763754 0.82 CA4 (0.44) GRIA4CA4CA12CA9CA1
SCHEMBL6761042 0.82 PPARG (0.55) GRIA4PPARGKMT2AKDM4E
SCHEMBL6765779 0.81 ALDH1A1 (0.52) GRIA4CA12CA9CA1CA2
SCHEMBL6763807 0.79 ALDH1A1 (0.47) GRIA4CA4CA12CA9CA1
SCHEMBL6762961 0.79 KDM4E (0.44) GRIA4ACACBAKR1C3AKR1C2HTT
SCHEMBL6573583 0.77 GRIA4 (0.48) GRIA4CA4CA12CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147612-A1 Sulfonamide derivatives DAVISON JOSHUA ZWICK (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147612-A1 Sulfonamide derivatives GRIN1, GRIN2A, GRIA1 GRIA4 9/4885CA4 2818/4885CA12 1432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.